Conserved and host-specific features of influenza virion architecture.
about
Replication-Competent Influenza A Viruses Expressing Reporter GenesM2e-Based Universal Influenza A VaccinesMAIT cells are activated during human viral infectionsUbiquitin in Influenza Virus Entry and Innate ImmunityExosomes and Their Role in the Life Cycle and Pathogenesis of RNA VirusesChemical Genomics Identifies the PERK-Mediated Unfolded Protein Stress Response as a Cellular Target for Influenza Virus InhibitionDisentangling Viral Membrane Fusion from Receptor Binding Using Synthetic DNA-Lipid ConjugatesHemagglutinin Spatial Distribution Shifts in Response to Cholesterol in the Influenza Viral Envelope.Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virionsAntibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.Influenza A virus ribonucleoproteins modulate host recycling by competing with Rab11 effectors.Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus.Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis.Development of an Alternative Modified Live Influenza B Virus Vaccine.Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus.Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicityBinding of RNA by the Nucleoproteins of Influenza Viruses A and B.Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.Amino acid changes in PB2 and HA affect the growth of a recombinant influenza virus expressing a fluorescent reporter proteinDefining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAsIntegrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions.Influenza virus-host interactomes as a basis for antiviral drug development.hCLE/C14orf166, a cellular protein required for viral replication, is incorporated into influenza virus particles.Two Cytoplasmic Acylation Sites and an Adjacent Hydrophobic Residue, but No Other Conserved Amino Acids in the Cytoplasmic Tail of HA from Influenza A Virus Are Crucial for Virus Replication.The landscape of viral proteomics and its potential to impact human health.Replication and Transmission of the Novel Bovine Influenza D Virus in a Guinea Pig Model.Filamentous influenza viruses.To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1.Site-specific S-acylation of influenza virus hemagglutinin: the location of the acylation site relative to the membrane border is the decisive factor for attachment of stearate.Role of Host Genes in Influenza Virus Replication.Genome-wide analysis of influenza viral RNA and nucleoprotein association.Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.Defining B cell immunodominance to virusesInfluenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.Clustering of Rab11 vesicles in influenza A virus infected cells creates hotspots containing the 8 viral ribonucleoproteins.RNA-Free and Ribonucleoprotein-Associated Influenza Virus Polymerases Directly Bind the Serine-5-Phosphorylated Carboxyl-Terminal Domain of Host RNA Polymerase II.Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate.KIF13A mediates trafficking of influenza A virus ribonucleoproteins.Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.
P2860
Q26746999-FEB32DB0-D129-44A3-9F35-C91B97CB5B56Q26783493-6EC9B379-566D-444B-B8AF-59E782845BE8Q27469032-A37FD6B5-54C0-42E5-92A9-3969B207F8BAQ28077694-72608FBB-678E-4C84-9688-EEE7CE0FA15FQ28084897-B69D2CCA-6267-4F80-BD4A-28D48FC8317DQ28833828-375DD8EC-06E0-429B-8AA4-DF277916D149Q30276368-3878F06C-51E4-4EF5-B044-90CB78AF7C0DQ30278402-DC2344B2-E82C-45D2-A70D-1737E7464883Q30369504-73F0A5A4-8456-4595-9702-B8EC1EC08427Q30376254-021A2692-E4FC-4A6E-82A7-2B871D787592Q30385238-82E74841-0655-4777-B19E-A2716F52ADFEQ30394893-596E6121-1656-46A5-B642-9AFE2ECBD67EQ30791826-A996B092-C457-48B8-9271-BA03CD178384Q33733453-4C45B4A4-0B8A-4F6C-B3EC-703F2324237FQ35869278-A57E2D51-9C43-4FAE-B0FC-057CCC51B060Q35893651-48A1AC30-E3A9-4CDF-AC71-26DAE1A4BD82Q36003473-1FC97103-4402-4DA3-9E49-58455E0BE824Q36138356-1CC23F35-5096-4471-8417-04516E21B197Q36229655-34AC28AF-13BE-4649-B6CF-4D99D64481FBQ36548570-09DD5E33-83B6-48E8-BB1E-A66627B1AE27Q36905953-5D866CEA-5C8C-4800-8FB0-FD5CF015C257Q37372252-C01B6567-0D0A-40FA-811B-320C50B25460Q37737812-3AE67D94-6540-4E79-9A06-E704C8F8EC17Q38364349-FC36AA78-46F3-4309-A023-8F214C35104FQ38811637-73F92C08-7AFE-4E92-8D6C-B8DBD07DA777Q38822395-94BA10DE-C425-45DA-A85B-4CBAEB82A912Q38834806-88F0A8DD-9E36-4A36-B193-5BE3FF33B738Q38882756-D7649134-0759-497F-94C8-85319BE3B875Q38903946-1FA08CCB-57E5-4CDE-97C8-26C33DDBAF82Q38944670-CD4DA0CA-BD8F-4E18-A07B-2004E986D3D7Q39393272-86AA45DE-8CE6-418A-8F6B-B846263A00D3Q40040753-6864A2E6-770C-42E0-8677-9AD452972A51Q40157020-571069DA-79D8-4EF0-B458-04B6C27D5C41Q40335009-6C8B68DE-B503-4984-A657-77D911D70D0BQ40459715-BA74894D-CADB-4792-BFA3-E7E3BBCF9D56Q40639022-F6A52BE8-5522-489A-AE6D-0735B7B409BFQ40705551-1A97AA8E-AD39-4415-B00E-4356DAB8A429Q45325239-D7C52E98-7479-4968-993A-0076070CBFD0Q45325839-A89FEAC5-DED4-4434-9F46-06A0AFE42A43Q47549109-E1814EDB-0043-4D91-BCFD-61F0486A6175
P2860
Conserved and host-specific features of influenza virion architecture.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Conserved and host-specific features of influenza virion architecture.
@ast
Conserved and host-specific features of influenza virion architecture.
@en
Conserved and host-specific features of influenza virion architecture.
@nl
type
label
Conserved and host-specific features of influenza virion architecture.
@ast
Conserved and host-specific features of influenza virion architecture.
@en
Conserved and host-specific features of influenza virion architecture.
@nl
prefLabel
Conserved and host-specific features of influenza virion architecture.
@ast
Conserved and host-specific features of influenza virion architecture.
@en
Conserved and host-specific features of influenza virion architecture.
@nl
P2093
P2860
P356
P1476
Conserved and host-specific features of influenza virion architecture.
@en
P2093
Benjamin Thomas
David Trudgian
Mónica Martínez-Alonso
Philip D Charles
Svenja S Hester
P2860
P2888
P356
10.1038/NCOMMS5816
P407
P577
2014-09-16T00:00:00Z
P5875
P6179
1041625236